This Review describes how the latest advances in so-called –omics technologies have helped to provide novel insights into the development and biology of oesophageal adenocarcinoma and its precursor lesion Barrett oesophagus. The authors discuss how these molecular profiles could improve patient management in the future, including early diagnosis and monitoring of response to therapy.
- Jamie M. J. Weaver
- Caryn S. Ross-Innes
- Rebecca C. Fitzgerald